HIT Consultant April 22, 2024
What You Should Know:
– Pelvital USA, Inc., a leading women’s health innovator, has announced the successful closing of an oversubscribed $5M seed-plus funding round. The investment round was led by Boomerang Ventures with new investors including Pier 70 Ventures, Life Science Angels, Tech Coast Angels Orange County, and Blue Pacific Fund.
– This additional $2.32M funding will significantly accelerate the commercialization of Flyte, their novel treatment for stress urinary incontinence (SUI).
Flyte: A Game-Changer for Women with SUI
Flyte is a revolutionary, FDA-cleared, and clinically proven treatment designed to address SUI and strengthen pelvic floor muscles. This accessible and easy-to-use solution offers women a non-invasive option to manage this common condition. The typical treatment regimen involves using...
Today's Sponsors
Today's Sponsor